Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -19.47% is 60% above its 5-year average of -48.24%, near the high end of its 5-year range (-80.39%–-19.47%).
As of the fiscal period ended Tuesday, June 30, 2026. 46.23% above its 12-month average of -36.21%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -19.47%.
RETURN ON INVESTED CAPITAL (ROIC)
-19.47%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-36.21%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-53.00%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-48.24%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-50.20%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
-51.04%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
-52.38%
CURRENT VS TTM AVG
+46.23%
CURRENT VS 3Y AVG
+63.26%
CURRENT VS 5Y AVG
+59.63%
CURRENT VS 10Y AVG
+61.21%
CURRENT VS 15Y AVG
+61.85%
CURRENT VS 20Y AVG
+62.83%
SECTOR MEDIAN · HEALTHCARE
-28.29%
median of 484 covered companies
CURRENT VS SECTOR MEDIAN
+31.17%
vs the sector median at left
Altimmune, Inc.
Market Cap
$519.25M
Return on Invested Capital (ROIC)
-19.47%
TTM Avg
-36.21%
3Y Avg
-53.00%
5Y Avg
-48.24%
Market Cap
$517.79M
Return on Invested Capital (ROIC)
-102.59%
TTM Avg
-133.31%
3Y Avg
-119.78%
5Y Avg
-99.25%
Market Cap
$517.73M
Return on Invested Capital (ROIC)
-34.79%
TTM Avg
-53.61%
3Y Avg
-51.25%
5Y Avg
-40.96%
Market Cap
$491.93M
Return on Invested Capital (ROIC)
-15.54%
TTM Avg
-22.63%
3Y Avg
-32.48%
5Y Avg
-46.23%
Market Cap
$491.55M
Return on Invested Capital (ROIC)
-5.29%
TTM Avg
-5.58%
3Y Avg
-6.88%
5Y Avg
-5.95%
Market Cap
$547.86M
Return on Invested Capital (ROIC)
-0.81%
TTM Avg
-8.59%
3Y Avg
-110.96%
5Y Avg
-102.03%
Market Cap
$551.09M
Return on Invested Capital (ROIC)
-18.20%
TTM Avg
-95.31%
3Y Avg
-87.63%
5Y Avg
-71.60%
Market Cap
$487.30M
Return on Invested Capital (ROIC)
-13.15%
TTM Avg
-33.80%
3Y Avg
-80.16%
5Y Avg
-71.70%
Market Cap
$481.33M
Return on Invested Capital (ROIC)
-2.19%
TTM Avg
-24.50%
3Y Avg
-28.59%
5Y Avg
-24.45%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Altimmune, Inc. (ALT) | $519.25M | -19.47% | -36.21% | -53.00% | -48.24% |
| Crescent Biopharma, Inc. (CBIO)vs › | $517.79M | -102.59% | -133.31% | -119.78% | -99.25% |
| Allogene Therapeutics, Inc. (ALLO)vs › | $517.73M | -34.79% | -53.61% | -51.25% | -40.96% |
| Evolus, Inc. (EOLS)vs › | $491.93M | -15.54% | -22.63% | -32.48% | -46.23% |
| NeoGenomics, Inc. (NEO)vs › | $491.55M | -5.29% | -5.58% | -6.88% | -5.95% |
| Delcath Systems, Inc. (DCTH)vs › | $547.86M | -0.81% | -8.59% | -110.96% | -102.03% |
| Immix Biopharma, Inc. (IMMX)vs › | $551.09M | -18.20% | -95.31% | -87.63% | -71.60% |
| Bright Minds Biosciences Inc. (DRUG)vs › | $487.30M | -13.15% | -33.80% | -80.16% | -71.70% |
| Arvinas, Inc. (ARVN)vs › | $481.33M | -2.19% | -24.50% | -28.59% | -24.45% |
| Contineum Therapeutics, Inc. (CTNM)vs › | $478.54M | -27.22% | -25.30% | -27.88% | -30.72% |
ROIC
-19.5%
ROE
-19.4%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -19.47% |
| 2026-03-31 | -29.88% |
| 2025-12-31 | -35.67% |
| 2025-09-30 | -43.95% |
| 2025-06-30 | -52.10% |
| 2025-03-31 | -66.59% |
| 2024-12-31 | -80.08% |
| 2024-09-30 | -80.39% |
| 2024-06-30 | -69.35% |
| 2024-03-31 | -57.03% |
| 2023-12-31 | -48.33% |
| 2023-09-30 | -55.20% |
| 2023-06-30 | -50.97% |
| 2023-03-31 | -52.29% |
| 2022-12-31 | -46.21% |
| 2022-09-30 | -42.30% |
| 2022-06-30 | -49.52% |
| 2022-03-31 | -54.44% |
| 2021-12-31 | -48.31% |
| 2021-09-30 | -38.42% |
| 2021-06-30 | -27.72% |
| 2021-03-31 | -24.51% |
| 2020-12-31 | -23.51% |
| 2020-09-30 | -21.33% |
| 2020-06-30 | -42.04% |
| 2020-03-31 | -54.88% |
| 2019-12-31 | -42.81% |
| 2019-09-30 | -82.37% |
| 2019-06-30 | -63.56% |
| 2019-03-31 | -63.25% |
| 2018-12-31 | -85.17% |
| 2018-09-30 | -61.01% |
| 2018-06-30 | -118.56% |
| 2018-03-31 | -95.99% |
| 2017-12-31 | -85.60% |
| 2017-09-30 | -52.77% |
| 2017-06-30 | -18.62% |
| 2017-03-31 | -67.77% |
| 2016-12-31 | -52.31% |
| 2016-09-30 | -4.89% |
| 2016-06-30 | -17.43% |
| 2016-03-31 | -36.15% |
| 2015-12-31 | -18.68% |
| 2015-09-30 | -27.47% |
| 2015-06-30 | -38.01% |
| 2015-03-31 | -30.93% |
| 2014-12-31 | -50.60% |
| 2014-09-30 | -61.76% |
| 2014-06-30 | -88.40% |
| 2014-03-31 | -102.03% |
| 2013-12-31 | -87.17% |
| 2013-09-30 | -44.42% |
| 2013-06-30 | -30.42% |
| 2013-03-31 | -34.92% |
| 2012-12-31 | -36.15% |
| 2012-09-30 | -32.31% |
| 2012-06-30 | -38.45% |
| 2012-03-31 | -42.83% |
| 2011-12-31 | -64.47% |
| 2011-09-30 | -99.67% |
| 2011-06-30 | -89.43% |
| 2011-03-31 | -120.46% |
| 2010-12-31 | -111.97% |
| 2010-09-30 | -192.02% |
| 2010-06-30 | -237.28% |
| 2010-03-31 | -196.74% |
| 2009-12-31 | -125.50% |
| 2009-09-30 | -95.86% |
| 2009-06-30 | -72.35% |
| 2009-03-31 | -94.98% |
| 2008-12-31 | -93.00% |
| 2008-09-30 | -94.71% |
| 2008-06-30 | -83.76% |
| 2008-03-31 | -20.58% |
| 2007-12-31 | -10.31% |
| 2007-09-30 | -0.63% |
| 2007-06-30 | 13.59% |
| 2007-03-31 | 1.62% |
| 2006-12-31 | 1.44% |
| 2006-09-30 | 1.31% |
| 2006-06-30 | 1.09% |
